IRCT201011225147N2CompletedPhase 3
The prevalence of side effect of Risperidone drug in patient with schizophrenia
Yasouj University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •the diagnosis of schizophrenia by a psychiatrist based on DSMIV-TR criteria, age 15 – 60 years, no history of use of any other drug over 6 months prior to the study, no history of any other systemic diseases such as epilepsy, hematological diseases, CVD, glaucoma
- •Exclusion criteria: poor cooperation, not coming for visits, incidence of serious side effects
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 4
comparison of two antipsychotics Risperidone and olanzapine in their effectiveness and side effects in treatment of Bipolar DisorderCTRI/2014/07/004800Dr Manjuprasad60
Not yet recruiting
Phase 4
A study of the safety of Risperidone with Olanzapine in new psychosis patientsCTRI/2024/07/071680DrRajendra Prasad Government Medical college
Recruiting
Phase 3
Investigation of the efficacy of Risperidone in the treatment of developmental stuttering in Persian-speaking children aged 5 to 10 yearsStuttering.Childhood onset fluency disorderF80.81IRCT20240527061909N1Babol University of Medical Sciences30
Completed
Not Applicable
Effect of Risperidone on psychosis?????? ???? ?? ???? ????.Mental and behavioural disorders due to use of other stimulants, including caffeineIRCT201311199858N5Vice chancellor for research, Tabriz University of Medical Sciences32
Recruiting
Phase 3
Comparison of the effectiveness of risperidone and aripiprazole in controlling aggression in inpatient adolescents with conduct disorderConduct disorder.Conduct disordersIRCT20210718051932N1niversity of social welfare and rehabilitation sciences62